ARKVIEW Trademark

Trademark Overview


On Monday, March 18, 2024, a trademark application was filed for ARKVIEW with the United States Patent and Trademark Office. The USPTO has given the ARKVIEW trademark a serial number of 98454987. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 26, 2024. This trademark is owned by Lumos Recovery Holding Company, LLC. The ARKVIEW trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Detoxification services, namely, alcohol detoxification services and drug detoxification services; Pharmacotherapy treatment services; Residential treatment programs, namely, detoxification and inpatient services; Outpatient treatment programs, namely, partial hospitalization (PHP) and intensive outpatient (IOP) services; Substance abuse rehabilitation programs; Dual diagnosis (mental health and addiction) treatment programs; Veteran's addition treatment; Mental health services, namely, depression, anxiety, autism co-occurring disorders, bipolar disorder, trauma and post-traumatic stress disorder, schizophrenia, borderline personality disorder, dissociative identity disorder, and attention-deficit/hyperactivity disorder; Cognitive behavioral therapy (CBT); Dialectical behavior therapy (DBT); Group therapy; Family therapy; Individual therapy; Substance abuse treatment, namely, alcohol addiction treatment, benzodiazepines (benzos) abuse treatment, cocaine rehab program, drug addiction tr...

General Information


Serial Number98454987
Word MarkARKVIEW
Filing DateMonday, March 18, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDetoxification services, namely, alcohol detoxification services and drug detoxification services; Pharmacotherapy treatment services; Residential treatment programs, namely, detoxification and inpatient services; Outpatient treatment programs, namely, partial hospitalization (PHP) and intensive outpatient (IOP) services; Substance abuse rehabilitation programs; Dual diagnosis (mental health and addiction) treatment programs; Veteran's addition treatment; Mental health services, namely, depression, anxiety, autism co-occurring disorders, bipolar disorder, trauma and post-traumatic stress disorder, schizophrenia, borderline personality disorder, dissociative identity disorder, and attention-deficit/hyperactivity disorder; Cognitive behavioral therapy (CBT); Dialectical behavior therapy (DBT); Group therapy; Family therapy; Individual therapy; Substance abuse treatment, namely, alcohol addiction treatment, benzodiazepines (benzos) abuse treatment, cocaine rehab program, drug addiction treatment, ecstasy abuse rehab, fentanyl addiction treatment, heroin addiction treatment, meth addiction treatment, opioid addiction treatment, painkiller addiction treatment, and polysubstance abuse treatment

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 18, 2024
Primary Code044
First Use Anywhere DateMonday, November 1, 2021
First Use In Commerce DateMonday, November 1, 2021

Trademark Owner History


Party NameLumos Recovery Holding Company, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCedarhurst, NY 11516

Trademark Events


Event DateEvent Description
Monday, March 18, 2024NEW APPLICATION ENTERED
Tuesday, April 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Thursday, September 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION E-MAILED
Thursday, September 26, 2024NON-FINAL ACTION WRITTEN